Keyphrases
Advanced Therapy Medicinal Products
12%
Allogeneic
7%
Apoptosis
12%
Articular Cartilage
7%
B-cell Lymphoma 2 (Bcl-2)
11%
BHRF1
9%
Bioprocess
14%
Bone Healing
10%
Bone Marrow
18%
Bone Marrow Cells
9%
Bone Marrow Mononuclear Cells
11%
Cardiac Repair
7%
Cartilage
7%
Cartilage Resurfacing
7%
CD105
7%
CD90
7%
Cell Therapy
25%
Cell Viability
7%
Cell-based
32%
Cell-derived
7%
Clinical Application
38%
Clinical Grade
37%
Clinical Translation
9%
Critical Quality Attributes
13%
Europe
9%
Extracellular Vesicles
10%
Focal Defect
12%
Gene Therapy
6%
Good Manufacturing Practice
21%
HLA-DR
14%
Human Mesenchymal Stem Cells (hMSCs)
30%
Immunopotency
7%
International Society
10%
Large Animal Model
7%
Long Bone
9%
Manufacturing Process
7%
Mesenchymal Stroma
13%
Mesenchymal Stromal Cells
62%
Multipotent
8%
Multipotent Mesenchymal Stromal Cells
39%
Osteoarthritis Treatment
7%
Osteochondral
9%
PLGA Scaffold
9%
Production Process
7%
Pseudarthrosis
14%
Regenerative Medicine
14%
Sheep
14%
Umbilical Cord Blood
10%
Wharton's Jelly
18%
WJ-MSCs
9%
Medicine and Dentistry
Advanced Therapy
12%
Adverse Event
6%
Articular Cartilage
12%
Biological Marker
9%
Cell Therapy
20%
Clinical Trial
12%
Cord Blood
12%
Engineered Tissue
9%
Ex Vivo
12%
Fracture Healing
5%
Hematopoietic Cell
5%
Human Leukocyte Antigen
9%
Iliac Crest
5%
Injury
12%
Knee
9%
Magnetic Resonance Imaging
8%
Medicine
27%
Mesenchymal Stem Cell
100%
Myocardial Infarction
8%
Nonunion
7%
Osteoarthritis
6%
Pseudarthrosis
14%
Quality of Life
5%
Tissue Regeneration
11%
Wharton Jelly
26%